Pancreatic Cancer
Pancreatic cancer is the fifth leading cause of cancer death in Western societies, with a five year survival rate of less than 10%. The treatment and survival of patients with pancreatic cancer has not changed for over thirty years because there has been little research into the molecular and cell biology associated with it. Our projects focus on translating basic scientific discoveries into the clinic. These include:
- Defining clinically and biologically relevant phenotypes of Pancreatic Cancer, primarily through our integral role in the Australian Pancreatic Cancer Genome Initiative which is part of the International Cancer Genome Consortium (see http://www.pancreaticcancer.net.au)
- Developing biomarkers of prognosis and therapeutic responsiveness with clinical utility
- Understanding molecular mechanisms of resistance to develop novel therapeutic strategies.
Staff
 Research OfficerDr Chris Scarlett |
 Research OfficerDr Marina Pajic |
| Research Officer Dr Jianmin Wu |
|
 Research AssistantAmanda Mawson |
 Research AssistantMarc Jones |
 Research AssistantPage Tobelmann |
 PhD StudentDr David Chang |
 PhD StudentJohana Susanto |
 PhD StudentEmily Colvin |
 Scientific OfficerMary-Anne Bracato |
 Technical OfficerLauren Kay |
 Clinical Research
CoordinatorAmber Johns |
 Clinical Research CoordinatorMichelle Thomas |
 Clinical Research
CoordinatorQuoc Nguyen |
 Clinical Research CoordinatorChristopher Toon |
 Administration AssistantCathy Axford |
 Tumour Bank CoordinatorMona Martyn-Smith |
| Honorary Researchers A/Prof Neil Merrett Dr Anthony Gill Dr Lorraine Chantrill Dr Liviu Lefter |
Data Clerks Tehara Wickremeratne Timothy Eviston Melanie Fentoullis |
News
Personalised medicine for cancer patients in a new technology era
MEDIA RELEASE:
15 Apr 2010
Published online today in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium (ICGC) describes the beginnings of a Brave New World, a new era of personalised medicine for cancer patients.
Emily Colvin wins Premier’s Award for Outstanding Cancer Research Scholar
26 May 2009
Garvan PhD student Emily Colvin has received the prestigious $10,000 Premier's Award for Outstanding Cancer Research Scholar from the Cancer Institute NSW for her research into pancreatic cancer. The news was announced at a gala ceremony late last week.
Nuns on the Run from Dubbo to Darlinghurst for Cancer
MEDIA RELEASE:
19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
